TY - JOUR
T1 - The microbial metabolite butyrate induces expression of Th1- associated factors in cD4+ T cells
AU - Kespohl, Meike
AU - Vachharajani, Niyati
AU - Luu, Maik
AU - Harb, Hani
AU - Pautz, Sabine
AU - Wolff, Svenja
AU - Sillner, Nina
AU - Walker, Alesia
AU - Schmitt-Kopplin, Philippe
AU - Boettger, Thomas
AU - Renz, Harald
AU - Offermanns, Stefan
AU - Steinhoff, Ulrich
AU - Visekruna, Alexander
N1 - Publisher Copyright:
© 2017 Kespohl, Vachharajani, Luu, Harb, Pautz, Wolff, Sillner, Walker, Schmitt-Kopplin, Boettger, Renz, Offermanns, Steinhoff and Visekruna.
PY - 2017/8/28
Y1 - 2017/8/28
N2 - Short-chain fatty acids (SCFAs), which are generated by the bacterial fermentation of dietary fibers, promote expansion of regulatory T cells (Tregs). Potential therapeutic value of SCFAs has been recently highlighted in the experimental models of T cell-mediated autoimmunity and allergic inflammation. These studies suggest that physiological intestinal concentrations of SCFAs within the millimolar range are crucial for dampening inflammation-mediated processes. Here, we describe opposing effects of SCFAs on T cell-mediated immune responses. In accordance with published data, lower butyrate concentrations facilitated differentiation of Tregs in vitro and in vivo under steady-state conditions. In contrast, higher concentrations of butyrate induced expression of the transcription factor T-bet in all investigated T cell subsets resulting in IFN-γ-producing Tregs or conventional T cells. This effect was mediated by the inhibition of histone deacetylase activity and was independent of SCFA-receptors FFA2 and FFA3 as well as of Na+- coupled SCFA transporter Slc5a8. Importantly, while butyrate was not able to induce the generation of Tregs in the absence of TGF-β1, the expression of T-bet and IFN-γ was triggered upon stimulation of CD4+ T cells with this SCFA alone. Moreover, the treatment of germ-free mice with butyrate enhanced the expression of T-bet and IFN-γ during acute colitis. Our data reveal that, depending on its concentration and immunological milieu, butyrate may exert either beneficial or detrimental effects on the mucosal immune system.
AB - Short-chain fatty acids (SCFAs), which are generated by the bacterial fermentation of dietary fibers, promote expansion of regulatory T cells (Tregs). Potential therapeutic value of SCFAs has been recently highlighted in the experimental models of T cell-mediated autoimmunity and allergic inflammation. These studies suggest that physiological intestinal concentrations of SCFAs within the millimolar range are crucial for dampening inflammation-mediated processes. Here, we describe opposing effects of SCFAs on T cell-mediated immune responses. In accordance with published data, lower butyrate concentrations facilitated differentiation of Tregs in vitro and in vivo under steady-state conditions. In contrast, higher concentrations of butyrate induced expression of the transcription factor T-bet in all investigated T cell subsets resulting in IFN-γ-producing Tregs or conventional T cells. This effect was mediated by the inhibition of histone deacetylase activity and was independent of SCFA-receptors FFA2 and FFA3 as well as of Na+- coupled SCFA transporter Slc5a8. Importantly, while butyrate was not able to induce the generation of Tregs in the absence of TGF-β1, the expression of T-bet and IFN-γ was triggered upon stimulation of CD4+ T cells with this SCFA alone. Moreover, the treatment of germ-free mice with butyrate enhanced the expression of T-bet and IFN-γ during acute colitis. Our data reveal that, depending on its concentration and immunological milieu, butyrate may exert either beneficial or detrimental effects on the mucosal immune system.
KW - Butyrate
KW - Inhibition of histone deacetylase activity
KW - Interferon-gamma
KW - Regulatory T cells
KW - Short-chain fatty acids
UR - http://www.scopus.com/inward/record.url?scp=85028375028&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2017.01036
DO - 10.3389/fimmu.2017.01036
M3 - Article
AN - SCOPUS:85028375028
SN - 1664-3224
VL - 8
JO - Frontiers in Immunology
JF - Frontiers in Immunology
IS - AUG
M1 - 1036
ER -